Bevacizumab and Breast Cancer: A Meta-Analysis of First-Line Phase III Studies and a Critical Reappraisal of Available Evidence

Background. Randomized studies have shown different magnitude of bevacizumab benefit in the treatment of advanced breast cancer. Regulatory agencies have modified bevacizumab treatment indications across different regions. In this study, we perform a meta-analysis of phase III studies aiming to inte...

Descripción completa

Detalles Bibliográficos
Autores principales: Rossari, José R., Metzger-Filho, Otto, Paesmans, Marianne, Saini, Kamal S., Gennari, Alessandra, de Azambuja, Evandro, Piccart-Gebhart, Martine
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2012
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3447373/
https://www.ncbi.nlm.nih.gov/pubmed/23008712
http://dx.doi.org/10.1155/2012/417673

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3447373/
https://www.ncbi.nlm.nih.gov/pubmed/23008712
http://dx.doi.org/10.1155/2012/417673

Ejemplares similares